Treatment Guidelines from The Medical Letter
FROM
ISSUE
135
Drugs for Parkinson's Disease
The full article is available to subscribers Subscriber Login   

Levodopa combined with carbidopa is still the most effective treatment for symptoms of Parkinson's disease. Dopamine agonists, the next most effective class of drugs, can be used alone before the introduction of levodopa or as an adjunct to levodopa. Addition of a peripherally-acting COMT inhibitor or an MAO-B inhibitor to levodopa can reduce motor fluctuations in patients with advanced disease. Amantadine may have mild symptomatic benefit and can decrease levodopa-induced dyskinesias. Anticholinergics are rarely used because of their adverse effects, but can be a useful addition to levodopa for control of tremor and drooling. Subcutaneous apomorphine should be available for rescue use in patients with "off" episodes. Deep brain stimulation is an option for patients with levodopa-induced motor complications and relatively intact cognition.

The motor symptoms of Parkinson's disease (PD) are caused primarily by progressive degeneration ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Drugs for Parkinson's Disease
Article code: 135a
 Electronic, downloadable article - $25